When these molecules, such as programmed death 1 (PD1), interact with their ligand programmed death-ligand 1 (PD-L1) on antigen-presenting cells, tumor cells, Th cells, or macrophages, the CD8+ T-cells remain inactive. The gene discussed is CD8A; the disease is neoplasm.